Detection Technology Oy · OMXHEX:DETEC
Detection Technology Oy — Q3 2025 Earnings Presentation
17 slides from Detection Technology Oy's earnings presentation, Oct 30, 2025
Slide 1: Q3 Business review January–September 2025
Q3 Business review January–September 2025 President and CEO Hannu Martola | 30 October 2025
Slide 2: Q3 2025 net sales and EBITA highlights
Q3 2025 24.7 -8.8 2.8 11.4 net sales, €m net sales change-% EBITA excluding NRI, €m EBITA-% excluding NRI (27.1) (10.6) (4.2) (15.3) 2 30.10.2025 Detection Technology | Business review January—September 2025 presentation
Slide 3: Q3: A challenging quarter, but the sentiment is improving
Q3: A challenging quarter, but the sentiment is improving Sales declined due to unfavourable currency effects and a decrease in demand for security applications Industrial sales -9% • Decline in low-cost legacy industrial line-scan sales in APAC • Significant growth in TFT flat panel detectors for i
Slide 4: Net sales by quarter
Net sales by quarter (EUR 1,000) 35,000 30,000 25,000 20,000 -8.8 15,000 (YOY change-%) 10,000 5,000 0 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 2022 2023 2024 2025 4 30.10.2025 Detection Technology | Business review January—September 2025 presentation
Slide 5: Operating margin (EBITA) excluding NRI
Operating margin (EBITA) excluding NRI (EUR 1,000) 6,000 25% 5,000 20% 4,000 16.3% 15.3% 15% 14.8% 3,000 12.7% 11.4% 9.9% 10.0% 10% 9.0% 2,000 7.4% 7.0% 6.5% 6.3% 5.2% 5.4% 5% 1,000 2.3% 0 0% Q122 Q222 Q322 Q422 Q123 Q223 Q323 Q423 Q124 Q224 Q324 Q424 Q125 Q225 Q325 EBITA excluding NRI (EUR 1,000) E
Slide 6: Q3 2025 sales split by regional business units
Q3 2025 sales split by regional business units NET SALES €m YOY CHANGE-% 2.6% 30.2% AMERICAS 0.6 -67.7 TOTAL NET SALES 24.7 €m APAC 16.6 -5.8 67.1% EMEIA 7.5 -0.2 6 30.10.2025 Detection Technology | Business review January—September 2025 presentation
Slide 7: Q3 2025 sales split by main applications
Q3 2025 sales split by main applications NET SALES €m YOY CHANGE-% 18.1% INDUSTRIAL 4.5 -9.2 39.8% TOTAL NET SALES 24.7 €m MEDICAL 10.4 -4.5 42.0% SECURITY 9.8 -12.8 7 30.10.2025 Detection Technology | Business review January—September 2025 presentation
Slide 8: Q1-Q3 net sales and EBITA
Q1-Q3 71.3 -6.0 5.9 8.3 net sales, €m net sales change-% EBITA excluding NRI, €m EBITA-% excluding NRI (75.9) (4.7) (9.7) (12.8) 8 30.10.2025 Detection Technology | Business review January—September 2025 presentation
Slide 9: Q1-Q3 2025 sales split by regional business units
Q1-Q3 2025 sales split by regional business units NET SALES €m YOY CHANGE-% 4.2% 24.6% AMERICAS 3.0 -32.9 TOTAL NET SALES 71.3 €m APAC 50.8 1.5 71.2% EMEIA 17.6 -18.0 9 30.10.2025 Detection Technology | Business review January—September 2025 presentation
Slide 10: Q1-Q3 2025 sales split by main applications
Q1-Q3 2025 sales split by main applications NET SALES €m YOY CHANGE-% 19.3% INDUSTRIAL 13.8 -0.5 36.1% TOTAL NET SALES 71.3 €m MEDICAL 31.8 7.1 44.6% SECURITY 25.8 -20.4 10 30.10.2025 Detection Technology | Business review January—September 2025 presentation
Slide 11: Key figures
Key figures Q3 2025 Q3 2024 Q1-Q3 2025 Q1-Q3 2024 FY 2024 Net sales, EUR 1,000 24,717 27,103 71,338 75,901 107,514 Change in net sales, % -8.8% 10.6% -6.0% 4.7% 3.6% EBITA excluding NRI 2,807 4,157 5,908 9,726 14,892 EBITA excluding NRI, % 11.4% 15.3% 8.3% 12.8% 13.9% Non-recurring items (NRI) -342
Slide 12: Events during the review period
Events during the review period Took measures to improve its profitability and to invest in focus areas that strengthen its competitiveness Carried out efficiency and reorganization activities across its global sites Estimated total cost savings around EUR 0.4 million in H2 2025 and EUR 1.5 million
Slide 13: DT2030 strategy – CMD 18 November
DT2030 strategy CMD We will outgrow the market by delivering smart, data-driven X-ray 18 November detectors that drive customer success through exceptional usability. 13 30.10.2025 Detection Technology | Business review January—September 2025 presentation
Slide 14: Sales expectation Q4 2025 and Q1 2026
Sales expectation Q4 2025 and Q1 2026 Industrial Medical Security to grow to grow to decline in Q4 in Q4 in Q4 Sales in APAC to remain stable, and in EMEIA and Americas to decline in Q4 YOY total net sales to decline by a single digit in Q4 and to grow double digit in Q1 2026 14 30.10.2025 Detection
Slide 15: Business outlook
Business outlook Detection Technology expects a single-digit year-on-year decline in total net sales for Q4 2025 and double-digit growth in Q1 2026. The geopolitical situation, new U.S. import tariffs, U.S. relations with other countries, China’s healthcare reform, and price competition especially i
Slide 16: Financial targets
FINANCIAL TARGETS MEDIUM TERM Annual MEDIUM TERM Operating ANNUAL Dividend or sales growth margin (EBITA) returned capital >10% 15% 30-60% 16 30.10.2025 Detection Technology | Business review January—September 2025 presentation
Slide 17: www.deetee.com
Detection Technology